ABC | Volume 113, Nº3, Setembro 2019

Atualização Atualização da Diretriz de Ressuscitação Cardiopulmonar e Cuidados Cardiovasculares de Emergência da Sociedade Brasileira de Cardiologia – 2019 Arq Bras Cardiol. 2019; 113(3):449-663 arrest with initial pulseless electrical activity (PEA). Resuscitation. 2012;83(8):946-52. 279. DonninoMW, Salciccioll JD, Howell MD, Cocchi MN, Giberson B, Berg K, et al. Time to administration of epinephrine and outcome after in-hospital cardiac arrest with non-shockable rhythms: retrospective analysis of large in-hospital data registry. BMJ. 2014 May 20;348:G3028. 280. WetschWA, Spöhr F, Teschendorf P, Böttiger BW, Padosh SA. Thrombolysis during cardio-pulmonary resuscitation. Dtsch Med Wochenschr. 2010;135(40):1983-8. 281. de Vos R, Oosterom L, Koster RW, de Haan RJ. Decisions to terminate resuscitation.ResuscitationCommittee.Resuscitation.1998;39(1-2):7-13. 282. Kern KB, Ewy GA, Voohees WD, Babbs CF, Tacker WA. Myocardial perfusion pressure: a predictor of 24-hour survival during prolonged cardiac arrest in dogs. Resuscitation. 1988;16(4):241-50. 283. Michael JR, Guerci AD, Koehler RC, Shi AY, Tsitlik J, Chandra N, al. Mechanisms by which epinephrine augments cerebral and myocardial perfusion during cardiopulmonary resuscitation in dogs. Circulation. 1984;69(4):822-35. 284. Lee SW. Drugs in resuscitation: an update. Singapore Med J. 2011;52(8):596-602. 285. Jacobs IG, Finn JC, JelinekGA, Oxer HF, Thompson PL. Effect of adrenaline on survival in out-of-hospital cardiac arrest: A randomized double-blind placebo-controlled trial. Resuscitation. 2011;82(9):1138-43. 286. Hagihara A, Hasegawa M, Abe T, Nagata T, Wakata Y, Miyazaki S. Prehospital epinephrine use and survival among patients with out- ofhospital cardiac arrest. JAMA. 2012;307(11):1161-8. 287. Machida M, Miura S, Matsuo K, Ishikura H, Saku K. Effect of intravenous adrenaline before arrival at the hospital in out-of-hospital cardiac arrest. J Cardiol. 2012;60(6):503-7. 288. Callaham M, Madsen CD, Barton CW, Saunders CE, Pointer J. A randomized clinical trial of high-dose epinephrine and norepinephrine vs standard-dose epinephrine in prehospital cardiac arrest. JAMA.1992;268(19):2667-72. 289. Brown CG, MartinDR, Pepe PE, StuevenH, Cummins RO, Gonzalez E, et al. A comparison of standard-dose and high-dose epinephrine in cardiac arrest outside the hospital. TheMulticenter High-Dose Epinephrine Study Group. N Engl J Med. 1992;327(15):1051-5. 290. Sherman BW, Munger MA, Foulke GE, RutherfordWF, Panacek EA. High- dose versus standard-dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy. 1997;17(2):242-7. 291. Stiell IG, Hebert PC, Weitzman BN, Wells GA, Raman S, Stark RM, et al. High-dose epinephrine in adult cardiac arrest. N Engl J Med. 1992;327(15):1045-50. 292. Goto Y, Maeda T, Goto Y. Effects of prehospital epinephrine during outof- hospital cardiac arrest with initial non-shockable rhythm: an observational cohort study. Crit Care. 2013;17(5):R188. 293. Nakahara S, Tomio J, Nishida M, Morimura N, Ichikawa M, Sakamoto T. Association between timing of epinephrine administration and intact neurologic survival following out-of-hospital cardiac arrest in Japan: a population-based prospective observational study. Acad Emerg Med. 2012;19(7):782-92. 294. Koscik C, Pinawin A, McGovern H, Allen D, Media DE, Ferguson T, et al. Rapid epinephrine administration improves early outcomes in out-of- hospital cardiac arrest. Resuscitation. 2013;84(7):915-20. 295. Aung K, Htay T. Vasopressin for cardiac arrest: a systematic review and metaanalysis. Arch Intern Med. 2005;165(1):17-24. 296. Kudenchuk PJ, Cobb LA, Copass MK, Cummins RO, Doherty AM, Fahrenbruch CE, et al. Amiodarone for resuscitation after out-of- hospital cardiac arrest due to ventricular fibrillation. N Engl J Med. 1999;341(12):871-8. 297. Jemmett ME, Kendal KM, Fourre MW, Burton JH. Unrecognized misplacement of endotracheal tubes in amixed urban to rural emergency medical services setting. Acad Emerg Med. 2003;10(9):961-5. 298. Weaver WD, Fahrenbruch CE, Johnson DD, Hallstrom AP, Cobb LA, Copass MK. Effect of epinephrine and lidocaine therapy on outcome after cardiac arrest due to ventricular fibrillation. Circulation. 1990;82(6):2027-34. 299. Herlitz J, Ekström L, Wennerblom B, Axelsson A, Bang A, Lindkyist J, et al. Lidocaine in out-of-hospital ventricular fibrillation. Does it improve survival? Resuscitation. 1997; 33(3):199-205. 300. Teo KK, Yusuf S, Furberg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. JAMA. 1993;270(13):1589-95. 301. Kudenchuk PJ, Newell C, White L, Fahrenbruch C, Rea T, Eisenberg M. Prophylactic lidocaine for post resuscitation care of patients with out-of-hospital ventricular fibrillation cardiac arrest. Resuscitation. 2013;84(11):1512-8. 302. Hassan TB, Jagger C, Barnett DB. A randomized trial to investigate the efficacy of magnesiumsulphate for refractory ventricular fibrillation. Emerg Med J. 2002;19(1):57-62. 303. Manz M, Jung W, Lueritz B. Effect of magnesium on sustained ventricular tachycardia. Herz. 1997; Jun;22( Suppl 1):51-5. 304. Markel DT, Gold LS, Allen J, Fahrenbruch CE, Rea TD, EisenbergMS, et al. Procainamide and survival in ventricular fibrillation out-of-hospital cardiac arrest. Acad Emerg Med. 2010;17(6):617-23. 305. Skrifvars MB, Pettilä V, Rosenberg PH, Castrén M. A multiple logistic regression analysis of in-hospital factors related to survival at six months in patients resuscitated from out-of-hospital ventricular fibrillation. Resuscitation. 2003;59(3):319-28. 306. LongstrethWT Jr, Copass MK, Dennis LK, Rauch-Matthews ME, StarkMS, CobbLA.Intravenousglucoseafterout-of-hospitalcardiopulmonaryarrest: a community-based randomized trial. Neurology. 1993;43(12):2534-41. 307. Engdahl J, Bang A, Lindqvist J, Herlitz J. Factors affecting short- and long- term prognosis among 1069 patients with out-of-hospital cardiac arrest and pulseless electrical activity. Resuscitation. 2001;51(1):17-25. 308. Weil MH, Rackow EC, Trevino R, Grundler W, Falk JL, Griffel MI. Difference in acid-base state between venous and arterial blood during cardiopulmonary resuscitation. N Engl J Med. 1986;315(3):153-6. 309. Stueven HA, Thompson BN, Aprahamian C, Tonsfeldt DJ. Calcium chloride: reassessment of use in asystole. Ann Emerg Med. 1984;13(9 Pt 2):820-2. 310. Stueven HA, Thompson B, Aprahamian C, Tonsfeldt DJ, Kastenson EH. The effectiveness of calcium chloride in refractory electromechanical dissociation. Ann Emerg Med. 1985;14(7):626-9. 311. Mentzelopoulos SD, Malachias S, Chamos C, Konstantopoulos D, Ntaidou T, Papastylianou A, et al. Vasopressin, steroids, and epinephrine and neurologically favorable survival after in-hospital cardiac arrest: a randomized clinical trial. JAMA. 2013;310(3):270-9. 312. Spöhr F, Arntz HR, Bluhmki E, Bode C, Carli P, Chamberlain D, et al. International multicentre trial protocol to assess the efficacy and safety of tenecteplase during cardiopulmonary resuscitation in patients with out- of-hospital cardiac arrest: the Thrombolysis in Cardiac Arrest (TROICA) Study. Eur J Clin Invest. 2005;35(5):315-23. 313. Keuper W, Dieker HJ, Brouwer MA, Verheugt FW. Reperfusion therapy in out-of-hospital cardiac arrest: current insights. Resuscitation. 2007;73(2):189-201. 314. Hedges JR, Syverud SA, Dalsey WC, Feero S, Easter R, Shultz B. Prehospital trial of emergency transcutaneous cardiac pacing. Circulation. 1987;76(6):1337-43. 315. Cummins RO, Graves JR, Larsen MP, Hallstrom AP, Hearne TR, Ciliberti J, et al. Out-of-hospital transcutaneous pacing by emergency medical 633